Cdk1/2 Inhibitor III – 1 mg

Brand:
Cayman
CAS:
443798-47-8
Storage:
-20
UN-No:
Non-Hazardous - /

Cyclin-dependent kinases (Cdks) are key regulators of cell cycle progression and are therefore promising targets for cancer therapy.{21810} Cdk1/2 Inhibitor III is a cell-permeable inhibitor of Cdk1/cyclin B and Cdk2/cyclin A (IC50s = 0.6 and 0.5 nM, respectively).{30420} It less potently inhibits CDC2-like kinases 1 and 3, VEGFR2, and GSK-3β (IC50s = 8.9, 29, 32, and 140 nM, respectively) and is without effect against a panel of other kinases.{30420,30419} Cdk1/2 Inhibitor III blocks the growth of several cancer cell lines (IC50 values range from 20 to 92 nM).{30420}  

 

Available on backorder

SKU: - Category:

Description

A cell-permeable inhibitor of Cdk1/cyclin B and Cdk2/cyclin A (IC50s = 0.6 and 0.5 nM, respectively); blocks the growth of several cancer cell lines (IC50 values range from 20 to 92 nM)


Formal name: 5-amino-3-[[4-(aminosulfonyl)phenyl]amino]-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide

Synonyms:  Cyclin-dependent kinase 1/2 Inhibitor III

Molecular weight: 425.4

CAS: 443798-47-8

Purity: ≥95%

Formulation: A solid


Product Type|Biochemicals|Kinase Inhibitors|CDKs||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Cycle||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling||Research Area|Cancer|Cell Signaling|GSK3 Signaling